相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials
Samuel J. P. Malkin et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
Barrie Chubb et al.
DIABETES THERAPY (2021)
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme
Kamlesh Khunti et al.
DIABETES OBESITY & METABOLISM (2020)
Advances in oral peptide therapeutics
Daniel J. Drucker
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study
Bjorn Pasternak et al.
DIABETES CARE (2020)
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Stephen C. Bain et al.
DIABETES THERAPY (2020)
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Daisuke Yabe et al.
Lancet Diabetes & Endocrinology (2020)
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial
Yuichiro Yamada et al.
Lancet Diabetes & Endocrinology (2020)
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
Sanjay Kalra et al.
DIABETES THERAPY (2020)
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Faidon Magkos et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea The PIONEER 3 Randomized Clinical Trial
Julio Rosenstock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects
Tine A. Baekdal et al.
CLINICAL PHARMACOKINETICS (2019)
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
Vanita R. Aroda et al.
DIABETES CARE (2019)
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
Richard Pratley et al.
LANCET (2019)
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Mansoor Husain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Thomas R. Pieber et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Ofri Mosenzon et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
Bernard Zinman et al.
DIABETES CARE (2019)
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Helena W. Rodbard et al.
DIABETES CARE (2019)
Glucagon-like peptide 1 (GLP-1)
T. D. Mueller et al.
MOLECULAR METABOLISM (2019)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Soren L. Kristensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials
V. R. Aroda et al.
DIABETES & METABOLISM (2019)
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Thomas R. Einarson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide
Tine A. Baekdal et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin
Chun Y. Wong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET (2018)
Related factors of quality of life of type 2 diabetes patients: a systematic review and meta-analysis
Xiyue Jing et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2018)
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial
Melanie Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Practical Review of C-Peptide Testing in Diabetes
Emma Leighton et al.
DIABETES THERAPY (2017)
A Practical Review of C-Peptide Testing in Diabetes
Emma Leighton et al.
DIABETES THERAPY (2017)
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
T. A. S. Aguirre et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit
M. Baxter et al.
DIABETIC MEDICINE (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prevalence of diabetes in Brazil over time: a systematic review with meta-analysis
Gabriela H. Telo et al.
DIABETOLOGY & METABOLIC SYNDROME (2016)
Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel
Christoph Kapitza et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes
Deirdre K. Tobias et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Diabetes treatment in patients with renal disease: Is the landscape clear enough?
Ioannis Ioannidis
WORLD JOURNAL OF DIABETES (2014)
Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?
Sachin K. Majumdar et al.
ENDOCRINE (2013)
Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function
Jason G. Barrera et al.
JOURNAL OF NEUROSCIENCE (2011)
Overview of Newer Agents: Where Treatment Is Going
Ralph A. DeFronzo
AMERICAN JOURNAL OF MEDICINE (2010)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides
Niels Vrang et al.
PROGRESS IN NEUROBIOLOGY (2010)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
Diana L. Williams et al.
ENDOCRINOLOGY (2009)
Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight
E. Bonora
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
